The diversity of p53/p21 transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-Cell lymphoma (DLBCL)

被引：0
|
作者：
Young, K. H.
Moller, M. B.
Colleoni, G. W. B.
Sanchez-Beato, A.
Kerbauy, F. R.
Leroy, K.
Piris, M. A.
Eickhoff, J. C.
Young, A. H.
Kanehira, K.
Cook, S.
Ranheim, E. A.
Kahl, B. S.
Olivier, M.
Campo, E.
Delabie, J.
Gaseoyne, R. D.
Rosenwald, A.
Braziel, R. M.
Jaffe, E. S.
Wilson, W. H.
Staudt, L. M.
Chan, W. C.
Weasenburger, D. D.
Greiner, T. C.
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[2] Odense Univ Hosp, DK-5000 Odense, Denmark
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
[4] Spanish Natl Canc Ctr, Madrid, Spain
[5] Hop Henri Mondor, Paris, France
[6] World Hlth Org, Lyon, France
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1217
引用
收藏
页码：265A / 266A
页数：2
相关论文
共 50 条
  • [1] The diversity of p53/p2l transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-Cell lymphoma (DLBCL)
    Young, K. H.
    Moller, M. B.
    Colleoni, G. W. B.
    Sánchez-Beato, M.
    Kerbauy, F. R.
    Leroy, K.
    Piris, M. A.
    Eickhoff, J. C.
    Young, A. H.
    Kanehira, K.
    Cook, S.
    Ranheim, E. A.
    Kahl, B. S.
    Olivier, M.
    Campo, E.
    Delabie, J.
    Gascoyne, R. D.
    Rosenwald, A.
    Braziel, R. M.
    Jaffe, E. S.
    Wilson, W. H.
    Staudt, L. M.
    Chan, W. C.
    Weisenburger, D. D.
    Greiner, T. C.
    MODERN PATHOLOGY, 2007, 20 : 265A - 266A
  • [2] Predictive value of TP53 RNAscope®in situ hybridization and p53 immunohistochemistry for TP53 mutational status in canine diffuse large B-cell lymphoma
    Foiani, Greta
    Licenziato, Luca
    Marconato, Laura
    Fanelli, Antonella
    Melchiotti, Erica
    Zanardello, Claudia
    Aresu, Luca
    Vascellari, Marta
    VETERINARY QUARTERLY, 2024, 44 (01) : 1 - 9
  • [3] Correlation of TP53 Aberrations with P53 Staining and Outcomes in Large B-Cell Lymphomas
    Bhavsar, Shweta
    Aggarwal, Nidhi
    Moore, Erika
    Yatsenko, Svetlana
    Swerdlow, Steven
    MODERN PATHOLOGY, 2019, 32
  • [4] Correlation of TP53 Aberrations with P53 Staining and Outcomes in Large B-Cell Lymphomas
    Bhavsar, Shweta
    Aggarwal, Nidhi
    Moore, Erika
    Yatsenko, Svetlana
    Swerdlow, Steven
    LABORATORY INVESTIGATION, 2019, 99
  • [5] Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
    Silden, Elisabeth
    Hjelle, Sigrun M.
    Wergeland, Line
    Sulen, Andre
    Andresen, Vibeke
    Bourdon, Jean-Christophe
    Micklem, David R.
    McCormack, Emmet
    Gjertsen, Bjorn Tore
    PLOS ONE, 2013, 8 (02):
  • [6] Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation
    Schneider, BG
    John-Aryankalayil, M
    Rowsey, JJ
    Dushku, N
    Reid, TW
    EXPERIMENTAL EYE RESEARCH, 2006, 82 (01) : 91 - 98
  • [7] Focus on the p53 gene and cancer:: Advances in TP53 mutation research
    Soussi, T
    HUMAN MUTATION, 2003, 21 (03) : 173 - 175
  • [8] MUTATIONS OF THE P53 GENE IN B-CELL LYMPHOMA
    ICHIKAWA, A
    HOTTA, T
    SAITO, H
    LEUKEMIA & LYMPHOMA, 1993, 11 (1-2) : 21 - 25
  • [9] Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
    Xinyi Li
    Danju Luo
    Liling Zhang
    Qiuhui Li
    Jun Fan
    Jiwei Zhang
    Bo Huang
    Ming Yang
    Xiu Nie
    Xiaona Chang
    Huaxiong Pan
    BMC Cancer, 23
  • [10] Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma
    Li, Xinyi
    Luo, Danju
    Zhang, Liling
    Li, Qiuhui
    Fan, Jun
    Zhang, Jiwei
    Huang, Bo
    Yang, Ming
    Nie, Xiu
    Chang, Xiaona
    Pan, Huaxiong
    BMC CANCER, 2023, 23 (01)
12345